Effect of continuing care based on network platform on patients with multiple myeloma

Abstract

Objective To explore the effect of network platform continuing care on patients with multiple myeloma. Methods A total of 80 patients with multiple myeloma in our hospital between January 2013 and January 2015 were included and randomly divided into observation group (n=40) and control group (n=40). All the patients received bortezomib. The routine nursing of follow-up at home once a week was performed in control group, additionally, the network platform continuing care was adopted in observation group. The effect of health education, the score of self-rating anxiety scale (SAS) and self-rating depression scale (SDS), incidence of adverse events and recurrence rate, and patients′ satisfaction were evaluated. Results The effect of health education in observation group was better than that in control group. The scores of SAS and SDS in observation group were lower than those in control group. The differences between two groups were statistically significant (P<0.01). The incidence of adverse events and recurrence rate in observation group were 2.50% and 0.00%, respectively, which were lower than those in control group. The differences between two groups were statistically significant (P<0.05). The patients′ satisfaction in observation group and control group was 97.50% and 72.50%, respectively. The difference between two groups was statistically significant (P<0.05). Conclusions The network platform continuing care can improve the effect of health education, reduce the incidence of adverse events and recurrence rate, increase patients′ satisfaction. Key words: Continuing care; Multiple myeloma; Health education; Network platform; Anxiety; Depression